{"id":"NCT01639339","sponsor":"Human Genome Sciences Inc., a GSK Company","briefTitle":"Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis","officialTitle":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-07-12","primaryCompletion":"2019-07-25","completion":"2020-03-12","firstPosted":"2012-07-12","resultsPosted":"2020-07-07","lastUpdate":"2021-03-19"},"enrollment":448,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Lupus Nephritis"],"interventions":[{"type":"BIOLOGICAL","name":"Placebo plus standard therapy","otherNames":[]},{"type":"BIOLOGICAL","name":"Belimumab 10 mg/kg plus standard therapy","otherNames":["BENLYSTAâ„¢"]},{"type":"DRUG","name":"Standard therapy","otherNames":[]}],"arms":[{"label":"Placebo plus standard therapy","type":"PLACEBO_COMPARATOR"},{"label":"Belimumab 10 mg/kg plus standard therapy","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy, safety, and tolerability of belimumab in adult patients with active lupus nephritis.","primaryOutcome":{"measure":"Double-blind Period: Percentage of Participants With Primary Efficacy Renal Response (PERR) at Week 104","timeFrame":"Week 104","effectByArm":[{"arm":"Placebo","deltaMin":32.3,"sd":null},{"arm":"Belimumab 10 mg/kg","deltaMin":43,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0311"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":10},"locations":{"siteCount":118,"countries":["United States","Argentina","Belgium","Brazil","Canada","China","Colombia","Czechia","France","Germany","Hong Kong","Hungary","Mexico","Netherlands","Philippines","Russia","South Korea","Spain","Taiwan","Thailand","United Kingdom"]},"refs":{"pmids":["37017254","36302567","36058429","34560137","32937045"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":78,"n":224},"commonTop":["Upper respiratory tract infection","Urinary tract infection","Diarrhoea","Nasopharyngitis","Arthralgia"]}}